These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 7589960)

  • 1. [Effect of T-activin and irradiation with a helium-neon laser on the status of the interleukin-2-dependent component of the proliferative response of mononuclear cells in rheumatoid arthritis].
    Parnes EIa; Alikhanov BA; Tkomachev IuK; Muromtsev AV
    Fiziol Cheloveka; 1995; 21(4):143-9. PubMed ID: 7589960
    [No Abstract]   [Full Text] [Related]  

  • 2. [The clinico-immunological effects of immunotherapy in patients with acute pyelonephritis].
    Driianskaia VE
    Lik Sprava; 1997; (4):89-92. PubMed ID: 9471386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunity of middle age and aged patients with tuberculosis and its changes during multimodality treatment by using T-activin].
    Adambekov DA; Litvinov VI; Mambetov KB; Koshmuratov AG; Sabyrbekova TS
    Probl Tuberk; 1998; (5):46-8. PubMed ID: 9866400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
    Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
    Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Principles of immunocorrective therapy using the thymus preparation T-activin].
    Arion VIa; Ivanushkin EF
    Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
    Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
    Sov Med; 1990; (6):111-3. PubMed ID: 2144365
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of using T-activin in the therapy of the newborn with suppurative surgical infection.
    Samsygin SA; Dolgina EN; Arion VYa ; Romanova LA; Shchevochkina GI; Ovchinnikova EA
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(3):269-76. PubMed ID: 2809182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients].
    Ianiushina VV
    Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of immunomodulating therapy in rheumatoid arthritis].
    Bassam B; Balabanova RM
    Ter Arkh; 1990; 62(5):32-5. PubMed ID: 2204139
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunomodulating therapy of rheumatoid arthritis].
    Balabanova RM; Barakat B
    Revmatologiia (Mosk); 1990; (3):38-44. PubMed ID: 2151541
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
    Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
    Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of immunomodulating and laser therapy in rheumatoid arthritis patients].
    Iarema NZ; Nazar PS; Zoria LV
    Vrach Delo; 1987 Apr; (4):59-61. PubMed ID: 3617643
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined immunomodulating therapy in rheumatoid arthritis].
    Oliunin IuA; Balabanova RM
    Ter Arkh; 1996; 68(5):13-6. PubMed ID: 9082588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T-cell immunity and immunomodulators in the comprehensive treatment of diffuse toxic goiter].
    Petunina NA; Balabolkin MI; Arion VIa
    Ross Med Zh; 1992; (5-12):19-24. PubMed ID: 1286263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ultrastructure of the blood lymphoid cells and the dynamics of cellular immunity indices in chronic lympholeukemia patients during immunocorrection with T-activin].
    Chuvirov GN; Markova TP
    Ter Arkh; 1986; 58(9):67-70. PubMed ID: 3787495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of T-activin therapy on indomethacin modulation of lymphoproliferative response in vitro of melanoma patients.
    Stanojević-Bakić N; Vucković-Dekić L; Milosević D; Sasić M
    Panminerva Med; 1998 Dec; 40(4):314-8. PubMed ID: 9973828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary autoimmune syndrome and immunomodulating lymphotropic therapy in acute pancreatitis].
    Zaĭrat'iants OV; Kolobov SV; Iarema IV; Shevchenko VP
    Arkh Patol; 2002; 64(6):51-6. PubMed ID: 12534231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
    Ivanova LA
    Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effectiveness of T-activin in the treatment of cutaneous forms of lupus erythematosus].
    Skripkin IuK; Biriukov AV; Stenina MA; Skripnik AIu; Korotkiĭ NG
    Vestn Dermatol Venerol; 1985 May; (5):8-11. PubMed ID: 3898631
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of T-activin in patients with sarcoidosis].
    Romanov VV; Khomenko IS; Ozerova LV; Gergert VIa
    Probl Tuberk; 1990; (4):15-7. PubMed ID: 2395843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.